Clovis Oncology, Inc. Operating Lease Liability
Clovis Oncology, Inc. had Operating Lease Liability of $20.25 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2022-11-09
- 2022-09-30: Operating Lease, Liability $20.25M.
- 2022-06-30: Operating Lease, Liability $21.50M.
- 2022-03-31: Operating Lease, Liability $22.56M.
- 2021-12-31: Operating Lease, Liability $23.14M.
| Period end | Operating Lease, Liability |
|---|---|
| 2022-09-30 | $20.25M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $21.50M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $22.56M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $23.14M 10-K · filed 2022-02-24 |
| 2021-09-30 | $24.09M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $25.16M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $26.68M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $27.57M 10-K · filed 2021-02-25 |
| 2020-09-30 | $27.85M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $28.66M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $22.61M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $24.01M 10-K · filed 2020-02-26 |
| 2019-09-30 | $23.71M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $20.50M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $21.27M 10-Q · filed 2019-05-07 |